SNT 3.23% 3.2¢ syntara limited

Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration, page-7

  1. 5,758 Posts.
    lightbulb Created with Sketch. 696
    pity

    https://www.gsk.com/en-gb/media/press-releases/ojjaara-momelotinib-approved-in-the-us-as-the-first-and-only-treatment-indicated-for-myelofibrosis-patients-with-anaemia/

    short term this will continue to be smacked
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.001(3.23%)
Mkt cap ! $41.29M
Open High Low Value Volume
3.1¢ 3.2¢ 3.1¢ $8.331K 268.7K

Buyers (Bids)

No. Vol. Price($)
1 300000 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 488373 3
View Market Depth
Last trade - 16.10pm 10/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.